This article contains some information on the use of inhaled medicines for COPD treatment that is no longer current.
More recent guidance is available from: “An update on the pharmacological management of stable COPD”. Information that is no longer current is indicated in pale text.
The progression of COPD can be slowed by providing support for patients to stop smoking, and encouraging regular exercise and annual influenza vaccination. The pharmacological treatment of COPD needs to be individualised according to the patient’s response; regular follow-up is an important part of this process. Short- and then long-acting bronchodilators are the mainstays of treatment, depending on the patient’s symptom severity. Reducing the risk of exacerbations and ensuring acute exacerbations are promptly and appropriately treated with oral corticosteroids and antibiotics (if indicated) are important roles undertaken in primary care.
This is part two of a two part article Part one can be read here